These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Therapy for experimental endocarditis due to Staphylococcus epidermidis. Kobasa WD; Kaye KL; Shapiro T; Kaye D Rev Infect Dis; 1983; 5 Suppl 3():S533-7. PubMed ID: 6635444 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis. Ein ME; Smith NJ; Aruffo JF; Heerema MS; Bradshaw MW; Williams TW Antimicrob Agents Chemother; 1979 Nov; 16(5):655-9. PubMed ID: 260880 [TBL] [Abstract][Full Text] [Related]
8. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Chambers HF; Sande MA Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747 [TBL] [Abstract][Full Text] [Related]
9. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133 [TBL] [Abstract][Full Text] [Related]
10. Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis. Wheat LJ; Smith JW; Reynolds J; Bemis AT; Treger T; Norton JA Antimicrob Agents Chemother; 1988 Jan; 32(1):63-7. PubMed ID: 2831815 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies. Archer GL; Johnston JL; Vazquez GJ; Haywood HB Rev Infect Dis; 1983; 5 Suppl 3():S538-42. PubMed ID: 6556710 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection. Lowy FD; Walsh JA; Mayers MM; Klein RS; Steigbigel NH Antimicrob Agents Chemother; 1979 Sep; 16(3):314-21. PubMed ID: 259421 [TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis. Rouse MS; Wilcox RM; Henry NK; Steckelberg JM; Wilson WR Antimicrob Agents Chemother; 1990 Feb; 34(2):273-6. PubMed ID: 2327776 [TBL] [Abstract][Full Text] [Related]
14. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits. Carrizosa J; Kobasa WD; Kaye D Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418 [TBL] [Abstract][Full Text] [Related]
15. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis. Perdikaris G; Giamarellou H; Pefanis A; Donta I; Karayiannakos P Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices. Archer GL Antimicrob Agents Chemother; 1978 Sep; 14(3):353-9. PubMed ID: 708013 [TBL] [Abstract][Full Text] [Related]
17. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci. Ramos MC; Ing M; Kim E; Witt MD; Bayer AS Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887 [TBL] [Abstract][Full Text] [Related]
18. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Miró JM; García-de-la-Mària C; Armero Y; Soy D; Moreno A; del Río A; Almela M; Sarasa M; Mestres CA; Gatell JM; Jiménez de Anta MT; Marco F; Antimicrob Agents Chemother; 2009 Oct; 53(10):4172-7. PubMed ID: 19620326 [TBL] [Abstract][Full Text] [Related]
19. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Climo MW; Patron RL; Archer GL Antimicrob Agents Chemother; 1999 Jul; 43(7):1747-53. PubMed ID: 10390234 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial prophylaxis of experimental endocarditis caused by Staphylococcus epidermidis. Baddour LM; Hill MM; Felty-Duckworth AM Infection; 1989; 17(2):90-6. PubMed ID: 2714864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]